Earnings summaries and quarterly performance for QUAKER CHEMICAL.
Executive leadership at QUAKER CHEMICAL.
Joseph Berquist
Chief Executive Officer and President
Jeewat Bijlani
Executive Vice President, Global Specialty and Chief Growth Officer
Jeffrey Fleck
Senior Vice President, Chief Global Supply Chain Officer
Robert Traub
Senior Vice President, General Counsel and Corporate Secretary
Steve Dassing
Principal Accounting Officer and Vice President, Corporate Controller
Thomas Coler
Chief Financial Officer
Board of directors at QUAKER CHEMICAL.
Charlotte Henry
Director
Fay West
Director
Jeffry Frisby
Lead Independent Director
Lucrèce Foufopoulos-De Ridder
Director
Mark Douglas
Director
Michael Barry
Chair of the Board
Nandita Bakhshi
Director
Russell Shaller
Director
Sanjay Hinduja
Director
William Osborne
Director
Research analysts who have asked questions during QUAKER CHEMICAL earnings calls.
Arun Viswanathan
RBC Capital Markets
6 questions for KWR
Jonathan Tanwanteng
CJS Securities
5 questions for KWR
Michael Harrison
Seaport Research Partners
5 questions for KWR
David Begleiter
Deutsche Bank
2 questions for KWR
Laurence Alexander
Jefferies
2 questions for KWR
Daniel Rizzo
Jefferies
1 question for KWR
Kevin Estok
Jefferies
1 question for KWR
Mike Harrison
Seaport Research Partners
1 question for KWR
Recent press releases and 8-K filings for KWR.
- Quaker Houghton reported strong Q4 2025 results with net sales of $468 million, a 6% increase year-over-year, and adjusted EBITDA up 11% to $72 million. Adjusted earnings per share increased 24% to $1.65.
- Organic volume declined less than 1% globally, but was boosted by 4% organic volume growth in Asia Pacific, marking its 10th consecutive quarter of growth in that region. Acquisitions contributed an additional 6% to sales in Q4 2025, with three acquisitions completed in 2025 adding approximately $95 million of annualized revenue.
- The company generated $136 million in operating cash flow for the full year 2025. For 2026, management anticipates underlying markets to remain flat but expects to achieve year-over-year adjusted EBITDA growth through share gains, gross margin improvement, and the full-year impact of acquisitions.
- Quaker Houghton continues to execute cost savings initiatives, including a 4% year-over-year decline in organic SG&A in Q4 2025 and the closure of its German manufacturing facility, which is expected to generate $2 million in cost savings in 2026 and $5 million annually from 2027.
- Quaker Houghton reported Q4 2025 adjusted EBITDA up 11% and adjusted earnings per share up 24% year-over-year, with net sales reaching $468 million, a 6% increase.
- For the full year 2025, non-GAAP diluted earnings per share were $7.02, and operating cash flow was $136 million. The company's net debt stood at $691 million, with a net leverage ratio of 2.3 times adjusted EBITDA.
- Organic volumes in Q4 2025 declined less than 1% but were offset by 4% share gains and a 6% contribution from acquisitions, notably Dipsol. Asia Pacific achieved its 10th consecutive quarter of organic volume growth.
- Looking to 2026, Quaker Houghton expects underlying markets to remain flat, but anticipates 2%-4% net share gains and year-over-year adjusted EBITDA growth. Gross margin percentage is targeted at 36%-37% for the full year.
- Strategic actions include the closure of the Dortmund manufacturing facility, projected to save $2 million in 2026 and $5 million annually from 2027. Capital expenditures are forecasted to be between 2.5% and 3.5% of sales in 2026.
- Quaker Houghton reported strong Q4 2025 results, with adjusted EBITDA up 11% and adjusted earnings per share increasing 24% compared to the prior year.
- Net sales for Q4 2025 reached $468 million, a 6% increase year-over-year, primarily driven by 4% share gains and a 6% contribution from acquisitions, despite organic volumes declining less than 1%.
- The Asia-Pacific segment continued its strong momentum, achieving 4% organic volume growth in Q4 2025, marking its tenth consecutive quarter of year-over-year volume growth.
- For the full year 2025, operating cash flow was $136 million, a decrease from $205 million in 2024, mainly due to higher restructuring costs and increased working capital.
- Looking ahead to 2026, the company anticipates underlying markets to remain flat but expects to deliver year-over-year adjusted EBITDA growth driven by continued share gains (targeting 2%-4%) and the full-year impact of 2025 acquisitions.
- Quaker Houghton reported net sales of $468.5 million for Q4 2025, an increase from $444.1 million in Q4 2024, and $1,888.6 million for the full year 2025, up from $1,839.7 million in FY 2024.
- Adjusted EBITDA for Q4 2025 was $71.9 million, an 11% increase year-over-year, while full-year 2025 Adjusted EBITDA was $299.2 million.
- Non-GAAP earnings per diluted share reached $1.65 in Q4 2025 and $7.02 for the full year 2025.
- The company generated $136 million in operating cash flow and executed $42 million in share repurchases for the full year 2025.
- As of December 31, 2025, the leverage ratio stood at 2.3x.
- Quaker Houghton reported Q4 2025 net sales of $468.5 million, a 6% year-over-year increase, and full year 2025 net sales of $1.89 billion.
- Non-GAAP earnings per diluted share for Q4 2025 increased 24% year-over-year to $1.65, with adjusted EBITDA reaching $71.9 million, an 11% increase.
- For the full year 2025, the company recorded a net loss of $2.5 million and a loss per diluted share of $0.14, primarily impacted by an $88.8 million impairment charge and $35.1 million in restructuring charges.
- In 2025, Quaker Houghton generated $136.5 million in operating cash flow, completed three strategic acquisitions, and returned $75.9 million to shareholders via dividends and share repurchases.
- Management projects end markets to remain stable in H1 2026 with potential for growth in H2 2026, and expects to achieve revenue and adjusted EBITDA growth in 2026.
- Quaker Houghton reported Q4 2025 net sales of $468.5 million, an increase of 6% year-over-year, with non-GAAP earnings per diluted share of $1.65, up 24% year-over-year, and adjusted EBITDA of $71.9 million, an 11% increase year-over-year.
- For the full year 2025, the company achieved net sales of $1.89 billion but recorded a GAAP net loss of $2.5 million, or $0.14 loss per diluted share, primarily due to an $88.8 million impairment charge and $35.1 million in restructuring charges.
- Excluding these items, full year 2025 non-GAAP net income was $123.2 million and non-GAAP earnings per diluted share were $7.02, with adjusted EBITDA of $299.2 million.
- In 2025, the company generated $136.5 million of operating cash flow and returned $75.9 million to shareholders through dividends and share repurchases.
- Management anticipates revenue and adjusted EBITDA growth in 2026, expecting end markets to remain stable in the first half with potential for incremental growth in the latter half.
- Quaker Houghton (KWR) reported strong Q3 2025 results, with adjusted EBITDA up 5% and adjusted earnings per share up 10% year-over-year. Net sales increased 7% to $494 million, driven by 3% organic volume growth and a 5% contribution from acquisitions, primarily Dipsol.
- The company generated $51 million in operating cash flow during Q3 2025, reducing its net leverage to 2.4 times. Year-to-date, KWR has returned approximately $62 million to shareholders through dividends and share repurchases.
- KWR achieved 5% global new business wins and saw notable strength in Asia-Pacific, which delivered an 8% increase in organic sales volumes. The company continues to focus on cost controls, with organic SG&A down approximately 3% year-to-date.
- For Q4 2025, Quaker Houghton anticipates another quarter of year-over-year revenue and adjusted EBITDA growth and expects to generate solid cash flow. The company expresses confidence in returning to growth in 2026 and beyond, supported by ongoing share gains and cost actions.
- KWR reported Q3 2025 net sales of $493.8 million, an increase of 6.8% year-over-year, with non-GAAP earnings per diluted share rising 10.1% to $2.08.
- Adjusted EBITDA for Q3 2025 was $82.9 million, up 5.5% compared to the prior year, and operating cash flow reached $51 million.
- The company's leverage ratio stood at 2.4x as of September 30, 2025, with total debt of $875 million and net debt of $703 million.
- Sales volumes increased 3% year-over-year in Q3 2025, driven by new business wins across all regions.
- Quaker Houghton reported net sales of $493.8 million in Q3 2025, an increase of 7% year-over-year, driven by a 3% rise in organic sales volumes.
- The company achieved non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08 for Q3 2025, with non-GAAP net income increasing 10% year-over-year.
- Adjusted EBITDA grew 5% year-over-year to $82.9 million, resulting in adjusted EBITDA margins of 16.8%.
- Quaker Houghton generated $51.4 million of operating cash flow and reduced its net leverage ratio to 2.4x as of September 30, 2025.
- Management anticipates the current soft market environment to persist through year-end but expects year-over-year revenue and earnings growth in the fourth quarter of 2025.
- Quaker Houghton reported net sales of $493.8 million in Q3 2025, marking a 7% increase year-over-year.
- Non-GAAP earnings per diluted share for Q3 2025 increased 10% year-over-year to $2.08.
- Adjusted EBITDA reached $82.9 million in Q3 2025, a 5% increase year-over-year, with an adjusted EBITDA margin of 16.8%.
- The company generated $51.4 million of operating cash flow in Q3 2025 and reduced its net leverage ratio to 2.4x.
Quarterly earnings call transcripts for QUAKER CHEMICAL.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
